NF-κB Activity Is Required for the Deregulation of c-myc Expression by the Immunoglobulin Heavy Chain Enhancer

This publication has 37 references indexed in Scilit:

• A-Myb Up-regulates Bcl-2 through a Cdx Binding Site in t(14;18) Lymphoma Cells
  Published by Elsevier ,2000
• Transcriptional Regulation of the Murine 3′ IgH Enhancer by OCT-2
  Immunity, 1999
• Identification of a homolog of the Cα3′/hs3 enhancer and of an allelic variant of the 3′IgH/hs1,2 enhancer downstream the human immunoglobulin α1 gene
  European Journal of Immunology, 1997
• Enhancer Complexes Located Downstream of Both Human Immunoglobulin Cα Genes
  The Journal of Experimental Medicine, 1997
• Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
  Genes & Development, 1994
• A class switch control region at the 3′ end of the immunoglobulin heavy chain locus
  Cell, 1994
• The mouse IgH 3′‐enhancer
  European Journal of Immunology, 1991
• Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide
  The Lancet, 1990
• A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus
  Nature, 1990
• Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cells
  Cell, 1984